UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 74.10
-1.20 (-1.59%)
Jul 30, 2026, 11:22 AM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 4.79 billion as of July 29, 2026. Its market cap has increased by 25.15% in one year.
Market Cap
4.79B
Enterprise Value
4.13B
Revenue
26.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
74.10
ChartMarket Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 4.79B, an increase of 177.32%. That is a compound annual growth rate of 19.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 4.79B | -11.86% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiGen Biopharmaceuticals Holdings | 5.64B |
| Savior Lifetec | 5.64B |
| TWi Biotechnology | 5.54B |
| Steminent Biotherapeutics | 5.14B |
| Mycenax Biotech | 5.08B |
| AnnJi Pharmaceutical | 4.98B |
| Medigen Biotechnology | 4.46B |
| Sinew Pharma | 4.41B |